Historical record - last NADAC publication: 8/23/2023

Product Information

PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0808 per EA under NDC 43547042603. Its NADAC has been published 235 times since Feb 27, 2019.

The High Outlier badge above means this manufacturer's average price in the Pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PIOGLITAZONE HCL 15 MG TABLET

Pioglitazone
$0.0808per EA
High Outlier

Strength

15 mg/1

NDC

43547042603

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/23/2023

Active Ingredients

PIOGLITAZONE

Approval Type

Generic (ANDA)

FDA Application

ANDA207806

On Market Since

5/20/2018

Pharmacological Classes

PPAR alpha
PPAR gamma
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor Activity
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 235 times since Feb 27, 2019, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0808 per EA
All-time high$0.1175 (May 13, 2020)
All-time low$0.0780 (Apr 19, 2023)
Median price$0.0935
Average price$0.0976
Largest weekly change+13.8% (Apr 22, 2020)
Weeks tracked235
Tracking sinceFeb 27, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+0.5%

5Y

-28.6%

All

-9.4%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0808 per EA (NDC 43547042603), effective Aug 23, 2023.

How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 9.4%. It has been tracked across 235 weekly CMS publications since Feb 27, 2019.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?

Since Feb 27, 2019, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0780 (Apr 19, 2023) to a high of $0.1175 (May 13, 2020), with a median of $0.0935 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE HCL 15 MG TABLET, is $0.0689 per EA — about 15% below PIOGLITAZONE HCL 15 MG TABLET.

Who manufactures PIOGLITAZONE HCL 15 MG TABLET?

PIOGLITAZONE HCL 15 MG TABLET (NDC 43547042603) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.